MIS
TEVA icon

Morningstar Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History

Morningstar Investment Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,505
Closed -$707K – 371
2024
Q3 		$707K Buy
40,505
+910
+2% +$15.9K 0.01% 239
2024
Q2 		$644K Sell
39,595
-587
-1% -$9.04K 0.01% 228
2024
Q1 		$580K Sell
40,182
-39,395
-50% -$497K 0.01% 219
2023
Q4 		$833K Buy
79,577
+40,314
+103% +$376K ﹤0.01% 241
2023
Q3 		$401K Buy
39,263
+2,076
+6% +$19.3K 0.01% 224
2023
Q2 		$281K Buy
37,187
+2,266
+6% +$18.4K ﹤0.01% 225
2023
Q1 		$308K Buy
34,921
+3,140
+10% +$31K ﹤0.01% 205
2022
Q4 		$311K Sell
31,781
-1,767
-5% -$15.4K ﹤0.01% 196
2022
Q3 		$292K Buy
33,548
+1,250
+4% +$11.1K ﹤0.01% 193
2022
Q2 		$256K Buy
32,298
+5,667
+21% +$49.4K ﹤0.01% 202
2022
Q1 		$245K Buy
26,631
+1,395
+6% +$11.6K ﹤0.01% 218
2021
Q4 		$202K Buy
25,236
+1,733
+7% +$15.6K ﹤0.01% 235
2021
Q3 		$233K Buy
23,503
+4,040
+21% +$37.8K ﹤0.01% 212
2021
Q2 		$195K Buy
19,463
+3,906
+25% +$41.3K ﹤0.01% 214
2021
Q1 		$176K Buy
+15,557
New +$178K ﹤0.01% 205
2020
Q4 		– Sell
-22,413
Closed -$198K – 216
2020
Q3 		$198K Sell
22,413
-626
-3% -$6.62K ﹤0.01% 198
2020
Q2 		$281K Sell
23,039
-1,450
-6% -$16.4K ﹤0.01% 181
2020
Q1 		$208K Sell
24,489
-436
-2% -$4.47K ﹤0.01% 194
2019
Q4 		$244K Sell
24,925
-4,410
-15% -$39.4K ﹤0.01% 179
2019
Q3 		$202K Sell
29,335
-2,926
-9% -$22.4K ﹤0.01% 187
2019
Q2 		$298K Buy
32,261
+9,102
+39% +$110K ﹤0.01% 189
2019
Q1 		$363K Sell
23,159
-2,944
-11% -$51.9K 0.01% 171
2018
Q4 		$403K Sell
26,103
-669
-2% -$13.7K 0.01% 164
2018
Q3 		$577K Sell
26,772
-1,489
-5% -$34.6K 0.01% 153
2018
Q2 		$687K Buy
28,261
+4,177
+17% +$85.2K 0.01% 146
2018
Q1 		$412K Sell
24,084
-325
-1% -$6.35K 0.01% 162
2017
Q4 		$463K Buy
24,409
+2,428
+11% +$36.5K 0.01% 160
2017
Q3 		$387K Buy
+21,981
New +$495K 0.01% 161
2015
Q1 		– Sell
-15,363
Closed -$884K – 218
2014
Q4 		$884K Sell
15,363
-9,035
-37% -$503K 0.04% 159
2014
Q3 		$1.31M Sell
24,398
-74,305
-75% -$3.94M 0.07% 142
2014
Q2 		$5.17M Sell
98,703
-81,543
-45% -$4.17M 0.3% 84
2014
Q1 		$9.52M Buy
180,246
+13,976
+8% +$646K 0.65% 47
2013
Q4 		$6.66M Buy
166,270
+31,155
+23% +$1.23M 0.5% 55
2013
Q3 		$5.08M Buy
135,115
+57,765
+75% +$2.25M 0.44% 59
2013
Q2 		$3.03M Buy
+77,350
New +$3.01M 0.32% 74

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morningstar Investment Services's TEVA Position: Q4 2024 in Review

Morningstar Investment Services sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 40,505 shares — an estimated $707K sold.

Morningstar Investment Services first reported a position in TEVA in Q2 2013 and held it in 35 quarters. The position peaked at $9.52M in Q1 2014. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Morningstar Investment Services reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 40,505 Teva Pharmaceuticals shares in Q4 2024, an estimated $707K.
  • Morningstar Investment Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 35 quarters.
  • Morningstar Investment Services's Teva Pharmaceuticals position peaked at $9.52M in Q1 2014.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.